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To evaluate the importance of human exposure to Rift
Valley fever virus in Chad, investigations were carried out
to determine specific antibody prevalence in domestic rumi-
nants during the 2002 rainy season. Results highlighted
recent, substantial, active transmission of this virus.
T
he virology laboratory of the unit of the Tropical
Medicine Institute of the French Defense Medical
Service (IMTSSA) investigated some cases of self-limit-
ing nonmalarious febrile syndromes occurring among sol-
diers stationed in Chad. By using C6/36 and Vero cell
lines, peripheral blood lymphocytes collected from two
soldiers on duty in Chad during the 2001 rainy season were
cocultured. Two strains of Rift Valley fever virus (RVFV)
were isolated and identified by using indirect immunoflu-
orescence, reverse transcriptase–polymerase chain reac-
tion, and sequencing (1,2). To determine the potential for
human exposure to RVFV, a seroprevalence investigation
evaluated antibody prevalence in sheep, goats, and horned
cattle among animals taken to slaughterhouses of
N’Djamena and Abéché during the 2002 rainy season.
RVFV is a member of the genus Phlebovirus, family
Bunyaviridae, and was first isolated in Kenya in 1930.
Transmitted by a wide variety of mosquitoes from several
genera, the virus may cause abortion in pregnant livestock
and high death rate in young animals. RVFV has caused
influenzalike disease in humans, and it occasionally leads
to more serious complications, such as retinitis, menin-
goencephalitis, or severe hemorrhagic fever with a high
death rate.
In Chad, RVFV has never been officially recognized by
either the World Health Organization or by the
International Office of Epizooties. Nevertheless, three
facts suggest that the virus is present in Chad’s animal pop-
ulation. First, RVFV is generally thought to exist in the
enzootic state in Central Africa in sheep and wild animals
(3). Second, a study undertaken by the Pasteur Institute of
Paris in collaboration with the EMVT (Département
Elevage et Médecine Vétérinaire Tropicale du Centre de
Coopération Internationale pour la Recherche en
Agronomie pour le Développement) showed that 4% of
sheep bred in Chad and Ethiopia had anti-RVFV neutraliz-
ing antibodies (4). Third, RVFV was identified in Sudan,
Niger (5), and Nigeria, countries that border Chad.
The Study
During the 2002 rainy season (August through
October), within the slaughterhouses of the cities of
N’Djamena (southwestern Chad between the 10th and
15th parallels, a few kilometers from Cameroon) and
Abéché (220 km east of N’Djamena), blood samples were
collected from randomly selected sheep, goats, and horned
cattle (Table 1). According to the veterinary services of
Chad’s Ministry for Breeding, these animals were born and
bred in Chad. Furthermore, they were gathered in parks a
maximum of 3 days before slaughter. Sites were selected
for their proximity to an area where French troops were
deployed and also because the N’Djamena slaughterhouse,
in particular, receives cattle from various parts of Chad.
Each sample was accompanied by information on the
age of the animal (teeth examination), species, sex, and
origin. Blood was centrifuged within 24 hours of collec-
tion. The serum was transferred into cryotubes and frozen
at –80°C so that samples would arrive at IMTSSA for
analysis still frozen (–20°C). Each sample was systemati-
cally tested for RVFV-specific immunoglobulin (Ig) G by
using an enzyme-linked immunosorbent assay (ELISA).
First, ELISA screening was done by using antigen capture
(by mouse hyperimmune ascitic fluid) and detecting spe-
cific IgG in the diluted serum (1/500). The antigen used
was a precipitate (polyethylene glycol 6000) of the super-
natant of Vero cells infected with the RVFVclone 13. (This
strain was isolated from a person in the Central African
Republic [6] and is probably less dangerous than other
strains for laboratory workers).
On the same ELISA plate as negative antigen, the
serum was tested with Dugbe, a non-cross-reactive
Nairovirus. All IgG-positive serum samples were retested
for IgG (with a negative, noninfected Vero antigen) and
IgM by using the M-antibody capture method. The most
frequently used techniques for detecting anti-RVFV anti-
bodies are immunofluorescence, plaque reduction neutral-
ization assay, and immunoenzymatic assays (7). Because
RVFV cross-reacts with many other phleboviruses (5), the
choice of techniques used for this study was influenced by
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Table 1. Number of blood samples per species and site 
Animal 
N’Djamena 
slaughterhouse 
Abéché 
slaughterhouse  Total 
Sheep  211  89  300 
Goats  102  37  139 
Horned 
cattle 
99  15  114 
Total  412  141  553 their sensitivity and specificity. Seroneutralization is
described as the reference method for specificity (no cross-
reaction with other phleboviruses) (7), but the need for cell
culture makes it unsuitable for screening large numbers of
serum samples (8). ELISA was preferred, since it is con-
sidered an efficient alternative in terms of sensitivity,
specificity, and ease of use (7,8).
Serum samples were considered positive when the ratio
between optical density associated with RVFV antigen and
that associated with the Dugbe antigen was >3.5. Serum
specimens demonstrating anti-RVFV IgG were validated
in parallel by immunotransfer (Western blot) with a high
threshold of positivity. Only serum samples containing
both specific antibodies against the envelope glycoproteins
(G1 and G2) and the nucleocapsid (NC) protein were con-
sidered positive. Comparative results between the two
techniques confirm high specificity of ELISA (97% of the
serum samples positive by ELISA were confirmed by
Western blot). This high specificity has been described
previously by crosschecking results with those of virus
neutralization assay (8).
Conclusions
The relatively high prevalence of RVFV (Table 2) com-
bined with the fact that 41% of IgG-positive animals are
also IgM-positive (in cattle, these antibodies appear on the
fourth day (9) after natural infection and persist for 2–6
months (10) underscore the seriousness of the situation in
Chad. Indeed, many articles describe how domestic rumi-
nants are an early and sensitive indicator of human epi-
demics (7) and how outbreaks of human infection are
preceded by amplification cycles among animals (7).
The 1987 epizootic-epidemic in Mauritania was pre-
dicted by the Pasteur Institute of Dakar; by using a seroepi-
demiologic study among domestic animals, researchers
showed that the virus had been circulating for at least 6
months in animal hosts and that an amplification cycle of
the disease was in progress (11). We fear that, as occurred
in Burkina Faso in 1987 (1), ecologic changes or climatic
conditions favorable to vector proficiency (e.g., periods of
intense rain associated with epizootic appearance in Kenya
[12] and South Africa [13]) can increase, in areas where
the virus circulates, antibody prevalence in animals and
can lead to human cases (4). This risk appears even more
important since human outbreaks are specifically preceded
by an increase of antibody prevalence among animal pop-
ulations. A study by the Pasteur institute of Paris showed
that 4% of sheep bred in Chad and Ethiopia had anti RVFV
antibodies (14), and these figures were repeatedly con-
firmed (4).
Data regarding origin (source and path) could not be
collected for animals led to the N’Djamena slaughterhouse
(all that was known was that they were born and bred in
Chad) and are imprecise for those received at the Abéché
slaughterhouse (local source not specified). Thus, charting
the distribution of RVFV-positive animals and the geo-
graphic distribution of the virus is not possible.
Nevertheless, the weak antibody prevalence in animals
killed in the Abéché slaughterhouse should be noted,
which allows us to conclude that this particular area is still
isolated from RVFV.
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Average 
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b 
animals (%) 
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IgG+ animals 
age <1 y (% of 
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that were IgG+ 
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animals 
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confirmed by WB 
IgM+ animals 
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